Professor Lambe will give an overview of the development and clinical testing which led to the licensure and rollout of the Oxford-AstraZeneca vaccine worldwide. In addition, she will discuss the lessons learnt to ensure we are better prepared for future pandemics.

Teresa Lambe is Professor of Vaccinology & Immunology and the Calleva Head of Vaccine Immunology at the University of Oxford. She is leading a research group which improves human health by controlling disease through vaccination – stopping epidemics before they become pandemics. Her team work on emerging and outbreak pathogens including Ebola, CCHF and SARS CoV-2. Prof Lambe is one of the Principal Investigators overseeing the Oxford/AstraZeneca vaccine programme.

In January 2020, she co-designed the vaccine, led the preclinical studies, and then oversaw the delivery of the immune results needed to support regulatory approval in late 2020. The vaccine has played a pivotal role in the fight against COVID-19.

See further details here.